Blonder Tongue Laboratories, Inc.
Blonder Tongue Laboratories, Inc. (BDRL) Revenue
Annual & quarterly revenue history · segment & region breakdown
BDRL · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsBlonder Tongue Laboratories, Inc. trailing twelve-month (TTM) revenue is $0.01B, a decrease of 15.50% year-over-year from $0.01B in FY2024.
Revenue trend
2024 – 2005 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2024-12-31 | $0.01B | -$0.00B | -15.50% |
| 2023-12-31 | $0.01B | -$0.00B | -27.06% |
| 2022-12-31 | $0.02B | +$0.00B | +14.99% |
| 2021-12-31 | $0.02B | -$0.00B | -3.82% |
| 2020-12-31 | $0.02B | -$0.00B | -17.45% |
| 2019-12-31 | $0.02B | -$0.00B | -8.59% |
| 2018-12-31 | $0.02B | -$0.00B | -6.77% |
| 2017-12-31 | $0.02B | +$0.00B | +3.45% |
| 2016-12-31 | $0.02B | +$0.00B | +7.46% |
| 2015-12-31 | $0.02B | -$0.01B | -28.10% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Blonder Tongue Laboratories, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Blonder Tongue Laboratories, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Blonder Tongue Laboratories, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BDRL revenue · 4 questionsBDRL's trailing twelve-month (TTM) revenue is $0.01B. That is a decrease of 15.50% year-over-year from $0.01B in FY2024.
▸ Source: FMP · Blonder Tongue Laboratories, Inc. SEC filings · GAAP · Blonder Tongue Laboratories, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026